- Home
- HCM vs PAX Comparison
HCM vs PAX Comparison
Compare HCM & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCM | PAX |
|---|---|---|
| Founded | 2000 | 1988 |
| Country | Hong Kong | Cayman Islands |
| Employees | 1796 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HCM | PAX |
|---|---|---|
| Price | $12.01 | $11.01 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $13.75 | ★ $18.00 |
| AVG Volume (30 Days) | 27.8K | ★ 904.7K |
| Earning Date | 03-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.81% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.60 | $12.99 |
| Revenue Next Year | $15.62 | $16.52 |
| P/E Ratio | ★ $5.49 | $25.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.72 | $10.72 |
| 52 Week High | $19.50 | $17.80 |
Technical Indicators
Market Signals| Indicator | HCM | PAX |
|---|---|---|
| Relative Strength Index (RSI) | 26.82 | 34.51 |
| Support Level | N/A | N/A |
| Resistance Level | $15.75 | $13.26 |
| Average True Range (ATR) | 0.32 | 0.42 |
| MACD | -0.06 | -0.11 |
| Stochastic Oscillator | 16.67 | 12.31 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
About PAX Patria Investments Limited
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.